M&G Plc bought a new position in shares of Global Medical REIT Inc. (NYSE:GMRE – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 19,349 shares of the company’s stock, valued at approximately $193,000.
Other institutional investors have also bought and sold shares of the company. Tidal Investments LLC boosted its stake in Global Medical REIT by 5.8% in the first quarter. Tidal Investments LLC now owns 27,499 shares of the company’s stock worth $241,000 after purchasing an additional 1,504 shares in the last quarter. CANADA LIFE ASSURANCE Co grew its stake in shares of Global Medical REIT by 2.2% during the first quarter. CANADA LIFE ASSURANCE Co now owns 74,528 shares of the company’s stock valued at $652,000 after purchasing an additional 1,592 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Global Medical REIT by 7.2% in the second quarter. Principal Financial Group Inc. now owns 30,107 shares of the company’s stock valued at $273,000 after purchasing an additional 2,033 shares in the last quarter. Oppenheimer & Co. Inc. raised its position in Global Medical REIT by 8.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 26,988 shares of the company’s stock worth $236,000 after purchasing an additional 2,146 shares during the last quarter. Finally, Creative Planning lifted its holdings in Global Medical REIT by 13.3% during the 3rd quarter. Creative Planning now owns 22,980 shares of the company’s stock worth $228,000 after buying an additional 2,702 shares in the last quarter. Institutional investors and hedge funds own 57.52% of the company’s stock.
Global Medical REIT Trading Down 0.2 %
NYSE GMRE opened at $8.96 on Friday. The company has a market cap of $587.67 million, a PE ratio of -448.00, a PEG ratio of 1.37 and a beta of 1.25. The company has a current ratio of 0.29, a quick ratio of 0.29 and a debt-to-equity ratio of 1.20. The stock has a 50 day moving average of $9.47 and a 200-day moving average of $9.20. Global Medical REIT Inc. has a 12 month low of $7.98 and a 12 month high of $11.59.
Global Medical REIT Announces Dividend
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Alliance Global Partners assumed coverage on Global Medical REIT in a research note on Thursday, September 19th. They set a “buy” rating and a $12.00 price target on the stock. Berenberg Bank assumed coverage on shares of Global Medical REIT in a research note on Friday, October 18th. They issued a “buy” rating and a $11.75 target price on the stock.
View Our Latest Analysis on GMRE
Global Medical REIT Company Profile
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More
- Five stocks we like better than Global Medical REIT
- What Are Growth Stocks and Investing in Them
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 11/4 – 11/8
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Trump’s Return: Which Sectors Will Benefit Most?
Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMRE – Free Report).
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.